Goodbody Wellness’ third store ‘proof-of-concept’

A leading UK quoted wellness and medicinal cannabis company, Sativa Group, has completed its initial phase of its Goodbody CBD Wellness store chain, by opening its third outlet in Clifton, Bristol, as ‘proof-of-concept’, and is now actively seeking franchisees to participate in its national franchise plan.

The new store in the ‘Clifton Triangle’, which the company describes as a thriving and vibrant primary retail destination, stocks a range of more than 50 CBD (cannabidiol) products and along with its outlets in Bath and Cirencester, it has a tasting bar for customers to sample CBD products and enjoy a cup of high quality CBD infused coffee.

CBD is a natural occurring extract derived from the Hemp plant, which is used as a natural alternative for those wanting to support their health and wellbeing in a completely natural way.

Goodbody Wellness said that the consumer experience consists of focused knowledge and support from highly trained staff that can advise customers about its range of products and the best way to use and apply the products.

The CBD enriched items for sale include skincare, tinctures, balms, bath bombs, vape oils, body oils and capsules. The company adds that CBD is believed to boost the body’s endocannabinoid system that works to restore homeostasis and balance.

Chris Jones, managing director of Goodbody Wellness, said: “It was a great launch weekend with customer feedback echoing the sentiments given about the first two stores. The customers really appreciate a prestige high-street brand which they can trust. It’s all about traceability, product testing, and balance.

“A welcome surprise was that the store opened for business a day early. We hadn’t even switched on the digital display boards and customers were knocking on the door. That gave the team an early chance to put their extensive training in to practice.”

Henry Lees-Buckley, chief executive of Sativa, said: “Goodbody has achieved this significant milestone in just eight months. It’s an important third CBD trading business to the group alongside George Botanicals and our direct CBD marketing channel, and a fellow group subsidiary to PhytoVista Laboratories.

“We expect to soon add the licenced growing of medicinal cannabis, once necessary approvals are in place, for research and development purposes through our collaboration agreement with Kings College London, which is looking at the potential benefits that medicinal cannabis might have on respiratory diseases.”

To introduce franchisees to its model, the company has a full-scale replica of a store at its Somerset headquarters alongside its bespoke training facility, and as its trading stores are within an hour’s drive, potential franchisees can experience the concept and witness trading first-hand.

About the Sativa Group
Sativa is a medicinal cannabis company, which focuses on the ‘smart-sourcing’ of the raw material, advanced extraction, manufacture, testing, distribution, and research and development of medicinal cannabis and CBD products.

The company joined the UK’s NEX Exchange market in 2018 as the UK’s first medicinal cannabis investment vehicle. Prior to the listing Geremy Thomas, spent 12-months researching the global medical cannabis and CBD industries.

The group’s activities include the Sativa Foundation, which awards research grants to academic institutions to undertake further research and development into the full spectrum of cannabinoids.